Discover how innovative lymphoma treatments are transforming patient outcomes, from targeted therapies to immunotherapy ...

Ostensibly, the reason is Hoppus’s new memoir Fahrenheit 182, which tells all about Blink’s rise and fall and recent ...

A number of recent trials have explored potential strategies for using immunotherapy in chronic lymphocytic leukemia (CLL).

Taking a patient's immune cells and targeting their cancer with them, which is called CAR T cell therapy, is showing promise ...

Follicular lymphoma is an indolent malignancy with a generally favorable prognosis, with survival often measured in decades.

Ellie Allen from Okehampton launched a fundraiser for canine T-cell lymphoma research following her dog Max's terminal ...

A 2012 study of patients with low-tumor-burden follicular lymphoma showed that the 4-year freedom from treatment failure rate ...

Memo del Bosque was diagnosed with Hodgkin’s lymphoma in 2017. This aggressive cancer primarily affects white blood cells ...

For slow-growing lymphomas, long-term survival is common, although they cannot be cured. More aggressive tumors are more dangerous, but a permanent cure is possible. The lymphoma type, its effects ...

People may be a candidate if they: can safely receive high dose chemotherapy and radiation have tumors that are responsive to drugs have relapsed, aggressive lymphoma that still responds to ...